A busy premarket brings a string of positive trading updates and regulatory wins across pharma, industrials, and consumer names, with GSK's China breakthrough and Renishaw (LSE:RSW)'s upgraded guidance setting the tone for a constructive open. Several smaller companies are also beating expectations, underlining a broader theme of resilience heading into the new earnings season.
GSK
GSK plc (LSE:GSK) climbed 0.28% to 2129.0p after securing approval from China's NMPA for Blenrep (belantamab mafodotin) in combination with bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma who have received at least one prior line of therapy. The approval is backed by the DREAMM-7 trial, which demonstrated a 42% reduction in the risk of death and nearly tripled median progression-free survival versus a daratumumab-based triplet regimen. China's multiple myeloma patient population represents a significant commercial opportunity, and the NMPA nod opens a market that GSK had not previously accessed with this combination.
Renishaw
Renishaw plc (LSE:RSW) upgraded its full-year guidance, now targeting FY2026 revenue of £775m–£805m and adjusted profit before tax of £145m–£165m. The revision is driven by a surge in orders from semiconductor, electronics manufacturing equipment, and aerospace and defence customers — three of the highest-growth verticals in precision engineering. The upgrade signals that Renishaw's exposure to advanced manufacturing capex cycles is translating directly into order momentum, and the breadth of the demand drivers reduces reliance on any single end market.
Mulberry
Mulberry Group plc (LSE:MUL) reported full-year sales growth of 5.7% for the 52 weeks to 28 March 2026, with the recovery accelerating sharply in the second half, where constant-currency revenues rose 13.6%. Every region delivered positive like-for-like growth in the period — a meaningful turnaround for a brand that has navigated a difficult luxury goods cycle. The H2 momentum suggests the strategic repositioning under current management is gaining traction with consumers, and the all-regions positive performance removes the geographic concentration risk that had weighed on sentiment.
Plus500
Plus500 Ltd. (LSE:PLUS) told the market it expects FY2026 revenue and EBITDA to come in ahead of consensus expectations after a strong first quarter characterised by record customer income and double-digit growth across both top-line and EBITDA metrics. The company attributed the performance to technology-led improvements in its trading platform. For a retail CFD broker, record customer income in a quarter marked by elevated macro volatility — tariff uncertainty, currency swings, and equity drawdowns — reflects the cyclical tailwind the business enjoys in turbulent markets.
Supreme
Supreme plc (AIM:SUP) revealed that FY26 revenue rose approximately 15% to around £265.0m, with adjusted EBITDA reaching approximately £40.6m — both described as materially ahead of analyst consensus. The scale of the beat points to strong execution across Supreme's diversified consumer goods portfolio, which spans vaping, sports nutrition, and lighting. Consistent outperformance against market expectations has been a feature of Supreme's recent reporting history, and this update reinforces that track record heading into the formal full-year results.
City of London Investment Group
City of London Investment Group PLC (LSE:CLIG), whose shares stand at 430.0p, reported that funds under management fell to $10.9bn in the quarter to 31 March, as $172m of net client redemptions combined with a sharp March market drawdown to offset targeted inflows. The picture has since improved materially: FuM recovered to $11.7bn by 15 April as markets stabilised. The swift recovery limits the damage to fee-earning assets, though the net outflow figure will remain a focus for investors assessing the group's organic growth trajectory.
Nanoco Group
Nanoco Group plc (AIM:NANO) posted H1 FY26 revenue of £7.7m, more than doubling the prior-year comparable of £3.4m, with adjusted EBITDA rising to £5.1m. The step-change was driven by a $5m licence settlement from LG Electronics, which combined with ongoing cost discipline to deliver a materially stronger half-year result. Nanoco's intellectual property monetisation strategy continues to generate meaningful cash returns, and the LG settlement adds to a growing track record of licensing income that underpins the group's financial position.
ATOME
ATOME PLC (AIM:ATOM) has extended the funding longstop date to 22 April to allow time to finalise equity documentation and financing arrangements for its US$650m, 260,000 tonne per annum Villeta green fertiliser plant in Paraguay. The extension is procedural rather than indicative of a deal breakdown, but the repeated pushing of longstop dates is a pattern that investors in early-stage green hydrogen projects will be watching closely. Successful financial close at Villeta would represent a significant de-risking event for ATOME's development pipeline.
The Smarter Web Company
The Smarter Web Company Plc (AIM:SWC) rose 1.98% to 35.0p after placing 4.29 million new shares under its December subscription agreement to raise £1.54m. The placing is a structured drawdown rather than a reactive fundraise, providing the company with additional working capital in an orderly fashion. For a micro-cap digital services business, the ability to access capital on pre-agreed terms reduces execution risk and signals that the relationship with its subscription counterparty remains intact.
Angus Energy
Angus Energy plc (AIM:ANGS) reported an approximately 30% uplift in production at its Saltfleetby gas field following completion of workover operations, generating estimated Q1 revenues of £5.24m. The operational improvement arrives as the company advances a legally binding financial restructuring, with shares remaining suspended on AIM pending resolution of that process. The production recovery strengthens Angus Energy's cash generation position at a critical juncture, providing a more constructive backdrop for restructuring negotiations.
Market Pulse
The dominant thread running through this morning's newsflow is outperformance against expectations — Supreme, Plus500, and Renishaw all either beat or upgraded consensus, while Nanoco's revenue more than doubled. This is not a sector-specific phenomenon: it spans consumer goods, fintech, precision engineering, and intellectual property licensing. The breadth of beats suggests that analyst models entering 2026 were set conservatively, and that companies with genuine operational leverage are now delivering the upside that cautious forecasts left on the table.
The macro backdrop adds context. Plus500's record customer income in Q1 reflects the volatility premium that retail trading platforms capture during periods of market stress, while Renishaw's semiconductor and defence order surge points to structural capex themes that are proving durable despite tariff uncertainty. For investors scanning the premarket, the signal is that selectivity is being rewarded — businesses with clear demand drivers and cost discipline are separating themselves from the pack.
